<DOC>
	<DOCNO>NCT02693054</DOCNO>
	<brief_summary>Characterizing safety efficacy Halo Laser Treatment Various Skin Conditions .</brief_summary>
	<brief_title>Safety Efficacy Study Various Skin Conditions</brief_title>
	<detailed_description>The purpose study demonstrate safety efficacy Halo treatment measure change skin tone , texture pigment .</detailed_description>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>Fitzpatrick Skin type I IV Desires improvement significant skin condition face and/or neck Willingness participate study signing inform consent form Will limit sun exposure least two week prior study screen study , include followup period Able adhere treatment followup schedule posttreatment care instruction Postmenopausal surgically sterilize female subject . History Halo resurface procedure treatment area within past six month Has tan within past thirty day unable unlikely refrain tanning , include use tan booth , tan spray , cream Has tattoo , dysplastic nevus treatment area Pregnant and/or lactating Is plan get pregnant within study period Has know history photosensitivity Has use medication photosensitize property within past six month , e.g . isotretinoin History evidence chronic recur skin disease disorder ( e.g . psoriasis , Netherton syndrome , etc . ) affect treatment area Has open laceration , abrasion , active cold sore , herpes sore Has hormonal disorder History keloid hypertrophic scar formation poor wound heal History immunosuppression immune deficiency disorder ( include HIV infection AIDS ) use immunosuppressive medication History bleed disorder take anticoagulation medication History skin cancer cancer treatment area Has significant concurrent illness , diabetes , lupus , epilepsy , cardiac disorder , might aggravate result treatment Has participate clinical trial involve investigational drug cosmetic product procedure within past thirty day The investigator feel reason subject eligible participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>